Clinical Trial Update: Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer [Phase 1]

View source ↗

Summary

The document reports an ongoing Phase 1 trial evaluating cabozantinib in combination with Enfortumab Vedotin for locally advanced or metastatic urothelial carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Enfortumab Vedotin (enfortumab vedotin)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Emory University | Conditions: Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma | Phase 1 | Status: RECRUITING